9" Din 2 1080P 4G 3G Wifi FM MP5 Radio Stereo 16GB + 1GB Quad-core 8.1 Android Other Car & Truck Interior Parts


  1. Home
  2. 9" Din 2 1080P 4G 3G Wifi FM MP5 Radio Stereo 16GB + 1GB Quad-core 8.1 Android
  1. facebook
  2. twitter
  3. linkedin
  4. pinterest
2 Din 9"  Android 8.1 Quad-core 1GB + 16GB Stereo Radio MP5 FM Wifi 3G 4G 1080P
Condition: New Brand:

Unbranded

Power Supply: DC 12V (allowance range: 10.8-14.5V) Front panel Size: 250mm(Top width)*146mm(High)*241mm(Bottom width)
Screen Size: 9 inch Manufacturer Part Number:

Does Not Apply

Type: New model with knobs and keys Max. Current: 10A
Warranty: 1 Year UPC:

7088393134123













published on tue nov 09 2021

9" Din 2 1080P 4G 3G Wifi FM MP5 Radio Stereo 16GB + 1GB Quad-core 8.1 Android Other Car & Truck Interior Parts

gandhi, s., klein, j., robertson, a., pena-hernandez, m. a.,

9" Din 2 1080P 4G 3G Wifi FM MP5 Radio Stereo 16GB + 1GB Quad-core 8.1 Android Other Car & Truck Interior Parts

lin, m. j., roychoudhury, p., lu, p., fournier, j., ferguson, d., mohamed bakhash, s. a., muenker, m. c., srivathsan, a., wunder, e. a., kerantzas, n., wang, w., pyle, a., wilen, c. b., ogbuagu, o., greninger ,, a. l., iwasaki, a., schulz, w. l., ko, a. i.

sars-cov-2 remdesivir resistance mutations have been generated in vitro but have not been reported in patients receiving treatment with the antiviral agent. we present a case of an immunocompromised patient with acquired b-cell deficiency who developed an indolent, protracted course of sars-cov-2 infection. remdesivir therapy alleviated symptoms and produced a transient virologic response, but her course was complicated by recrudescence of high-grade viral shedding. whole genome sequencing identified a mutation, e802d, in the nsp12 rna-dependent rna polymerase which was not present in pre-treatment specimens. in vitro experiments demonstrated that the mutation conferred a ~6-fold increase in remdesivir ic50 but resulted in a fitness cost in the absence of remdesivir. sustained clinical and virologic response was achieved after treatment with casirivimab-imdevimab. although the fitness cost observed in vitro may limit the risk posed by e802d,

, this case illustrates the importance of monitoring for remdesivir resistance and the potential benefit of combinatorial therapies in immunocompromised patients with sars-cov-2 infection.

509
1.2k
EVGENIA.RU RSS